Direct-to-consumer genomics on the scales of autonomy
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Direct-to-consumer (DTC) genetic services have generated enormous controversy from their first emergence. A dramatic recent manifestation of this is the Food and Drug Administration's (FDA) cease and desist order against 23andMe, the leading provider in the market. Critics have argued for the restrictive regulation of such services, and even their prohibition, on the grounds of the harm they pose to consumers. Their advocates, by contrast, defend them as a means of enhancing the autonomy of those same consumers. Autonomy emerges as a key battle-field in this debate, because many of the ‘harm’ arguments can be interpreted as identifying threats to autonomy. This paper assesses whether DTC genomic services are a threat to, or instead, an enhancement of, personal autonomy. It deploys Joseph Raz's account of personal autonomy, with its emphasis on choice from a range of valuable options. It then seeks to counter claims that DTC genomics threatens autonomy because it involves manipulation in contravention of consumers’ independence or because it does not generate valuable options which can be meaningfully engaged with by consumers. It is stressed that the value of the options generated by DTC genomics should not be judged exclusively from the perspective of medical actionability, but should take into consideration plural utilities. Finally, the paper ends by broaching policy recommendations, suggesting that there is a strong autonomy-based argument for permitting DTC genomic services, and that the key question is the nature of the regulatory conditions under which they should be permitted. The discussion of autonomy in this paper helps illuminate some of these conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Decision aids for people facing health treatment or screening decisions
Stacey, D., Légaré, F., Lewis, K., Barry, M. J., Bennett, C. L., Eden, K. B., Holmes-Rovner, M., Llewellyn-Thomas, H., Lyddiatt, A., Thomson, R., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001431.pub5 · Cited by 6,685
Raz, J. (1988) · doi:10.1093/0198248075.001.0001 · Cited by 2,895
Decision aids for people facing health treatment or screening decisions
Stacey, D., Bennett, C. L., Barry, M. J., Col, N. F., Eden, K. B., Holmes-Rovner, M., Llewellyn-Thomas, H., Lyddiatt, A., Légaré, F., & Thomson, R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001431.pub3 · Cited by 849
Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk
Bloss, C. S., Schork, N. J., & Topol, E. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011893 · Cited by 562
Some limits of informed consent
O'Neill, O. (2003) · Journal of Medical Ethics · doi:10.1136/jme.29.1.4 · Cited by 499
Evaluating the utility of personal genomic information
Foster, M. W., Mulvihill, J. J., & Sharp, R. R. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e3181a2743e · Cited by 180
Neumann, P. J., Cohen, J. T., Hammitt, J. K., Concannon, T. W., Auerbach, H. R., Fang, C., & Kent, D. M. (2010) · Health Economics · doi:10.1002/hec.1704 · Cited by 148
Impact of direct-to-consumer genomic testing at long term follow-up
Bloss, C. S., Wineinger, N. E., Darst, B. F., Schork, N. J., & Topol, E. J. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101207 · Cited by 137
Direct-to-Consumer Genetic Testing: Perceptions, Problems, and Policy Responses
Caulfield, T., & McGuire, A. L. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-062110-123753 · Cited by 126
Genetics, biosocial groups & the future of identity
Hacking, I. (2006) · Daedalus · doi:10.1162/daed.2006.135.4.81 · Cited by 113
Personalized Genomic Medicine and the Rhetoric of Empowerment
Juengst, E. T., Flatt, M. A., & Settersten, R. A. (2012) · The Hastings Center Report · doi:10.1002/hast.65 · Cited by 113
Dealing with the unexpected: consumer responses to direct-access BRCA mutation testing
Francke, U., Dijamco, C., Kiefer, A. K., Eriksson, N., Moiseff, B., Tung, J. Y., & Mountain, J. L. (2013) · PeerJ · doi:10.7717/peerj.8 · Cited by 92
Skirton, H., Goldsmith, L., Jackson, L., & O'Connor, A. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01863.x · Cited by 81
Willingness to Pay for Genetic Testing for Alzheimer's Disease: A Measure of Personal Utility
Kopits, I. M., Chen, C. A., Roberts, J. S., Uhlmann, W. R., & Green, R. C. (2011) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2011.0028 · Cited by 73
Sterckx, S., Cockbain, J., Howard, H. C., Huys, I., & Borry, P. (2012) · Genetics in Medicine · doi:10.1038/gim.2012.143 · Cited by 68
Regulating direct-to-consumer genetic tests: What is all the fuss about?
Wright, C. F., Hall, A., & Zimmern, R. L. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181f69dd2 · Cited by 64
Singleton, A., Erby, L. H., Foisie, K. V., & Kaphingst, K. A. (2012) · Journal of Genetic Counseling · doi:10.1007/s10897-011-9474-6 · Cited by 63
Experiences of Early Users of Direct-to-Consumer Genomics in Switzerland: An Exploratory Study
Vayena, E., Gourna, E., Streuli, J. C., Hafen, E., & Prainsack, B. (2012) · Public Health Genomics · doi:10.1159/000343792 · Cited by 62
Self-citationPersonal genome testing in medical education: student experiences with genotyping in the classroom
Vernez, S. L., Salari, K., Ormond, K. E., & Lee, S. S. (2013) · Genome Medicine · doi:10.1186/gm428 · Cited by 62
Henderson, G. E. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31822a6c47 · Cited by 61 · cited 1×
“15 16 Instead, DTC genomics should comply with consumer protection legislation that is more generally applicable.”
BackgroundHoward, H. C., Avard, D. M., & Borry, P. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.94 · Cited by 59
Health-Care Referrals from Direct-to-Consumer Genetic Testing
Giovanni, M. A., Fickie, M. R., Lehmann, L. S., Green, R. C., Meckley, L. M., Veenstra, D., & Murray, M. F. (2010) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0051 · Cited by 59
Informed consent: A broken contract
Check Hayden, E. (2012) · Nature · doi:10.1038/486312a · Cited by 53
Bunnik, E. M., Janssens, A. C. J. W., & Schermer, M. (2012) · Bioethics · doi:10.1111/bioe.12004 · Cited by 50
Perceptions of genetic counseling services in direct‐to‐consumer personal genomic testing
Darst, B., Madlensky, L., Schork, N. J., Topol, E. J., & Bloss, C. S. (2013) · Clinical Genetics · doi:10.1111/cge.12166 · Cited by 42
Association between health-service use and multiplex genetic testing
Reid, R. J., McBride, C. M., Alford, S. H., Price, C. S., Baxevanis, A. D., Brody, L. C., & Larson, E. B. (2012) · Genetics in Medicine · doi:10.1038/gim.2012.52 · Cited by 42
Rahman, B., Meiser, B., Sachdev, P. S., Barlow-Stewart, K. K., Otlowski, M. F. A., Zilliacus, E. M., & Schofield, P. R. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2011.0300 · Cited by 40
Howard, H. C., Borry, P., & Knoppers, B. M. (2010) · EMBO Reports · doi:10.1038/embor.2010.105 · Cited by 39
Playing a Part in Research? University Students' Attitudes to Direct-To-Consumer Genomics
Vayena, E., Ineichen, C., Stoupka, E., & Hafen, E. (2014) · Public Health Genomics · doi:10.1159/000360257 · Cited by 35
Self-citationBeyond the Clinic: ‘Direct-to-Consumer‘ Genomic Profiling Services and Pharmacogenomics
Prainsack, B., & Vayena, E. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.10 · Cited by 35
Self-citationThe autonomy paradox: predictive genetic testing and autonomy: three essential problems
Huibers, A., & Spijker, A. V. ’. (1998) · Patient Education and Counseling · doi:10.1016/s0738-3991(98)00083-4 · Cited by 34
Self Diagnosis of Lynch Syndrome Using Direct to Consumer Genetic Testing: A Case Study
Roberts, M. E., Riegert‐Johnson, D. L., & Thomas, B. C. (2011) · Journal of Genetic Counseling · doi:10.1007/s10897-011-9356-y · Cited by 22
23 and Me, We, and You: direct-to-consumer genetics, intellectual property, and informed consent
Allyse, M. A. (2012) · Trends in biotechnology · doi:10.1016/j.tibtech.2012.11.007 · Cited by 18
Law's virtues: fostering autonomy and solidarity in American society
(2013) · Choice Reviews Online · doi:10.5860/choice.50-5878 · Cited by 17
Direct-to-Consumer Genetic Testing: Reliable or Risky?
Spencer, D. H., Lockwood, C. M., Topol, E. J., Evans, J. P., Green, R. C., Mansfield, E. A., & Težak, Ž. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.167197 · Cited by 17
Direct-to-consumer genetic testing for health-related purposes in the European Union
Easac, ter Meulen, V., Boccia, S., Cornel, M. C., Delpech, M., Paepe, A. D., Estivill, X., HANSSON, M. G., Karalis, K., Metspalu, A., et al. (2012) · Cited by 17
Beckman, L. (2004) · Metamedicine · doi:10.1007/s11017-004-2047-z · Cited by 15
Nonpropositional Content in Direct-to-Consumer Genetic Testing Advertisements
Borry, P., Shabani, M., & Howard, H. C. (2013) · The American Journal of Bioethics · doi:10.1080/15265161.2013.776358 · Cited by 13
The challenge of personal genomics in Germany
Vayena, E., & Prainsack, B. (2013) · Nature Biotechnology · doi:10.1038/nbt.2469 · Cited by 13
Self-citationRegulating Genomics: Time for a Broader Vision
Vayena, E., & Prainsack, B. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005797 · Cited by 13
Self-citationDirect-to-Consumer Genomic Testing Offers Little Clinical Utility but Appears to Cause Minimal Harm
Adams, S. D., Evans, J. P., & Aylsworth, A. S. (2013) · North Carolina Medical Journal · doi:10.18043/ncm.74.6.494 · Cited by 11
Law�s Virtues: Fostering Autonomy and Solidarity in American Society
Caudill, D. S. (2013) · Catholic education/Catholic education (Dayton, Ohio. Online) · doi:10.15365/joce.1701122013 · Cited by 5
Direct-to-Consum er Genetic Testing: Personalized Medicine in Evolution
Leachman, S. A., MacArthur, D. G., Angrist, M. H., Gray, S. W., Bradbury, A. R., & Vorhaus, D. B. (2011) · Cited by 4
Cited by
Roberts, J. S., Gornick, M. C., Carere, D. A., Uhlmann, W. R., Ruffin, M. T., & Green, R. C. (2017) · Public Health Genomics · doi:10.1159/000455006 · Cited by 166
Kohlmeier, M., Caterina, R. D., Ferguson, L. R., Görman, U., Allayee, H., Prasad, C., Kang, J. X., Nicoletti, C. F., & Martínez, J. A. (2016) · Lifestyle Genomics · doi:10.1159/000446347 · Cited by 154
Sequencing Newborns:A Call for Nuanced Use of Genomic Technologies
Johnston, J., Lantos, J. D., Goldenberg, A. J., Chen, F., Parens, E., Koenig, B. A., & members of the NSIGHT Ethics and Policy Advisory Board (2018) · The Hastings Center Report · doi:10.1002/hast.874 · Cited by 135
Blasimme, A., & Vayena, E. (2016) · BMC Medical Ethics · doi:10.1186/s12910-016-0149-6 · Cited by 94
Self-citationLegislation of direct-to-consumer genetic testing in Europe: a fragmented regulatory landscape
Kalokairinou, L., Howard, H. C., Slokenberga, S., Fisher, E., Flatscher-Thöni, M., Hartlev, M., van Hellemondt, R., Juškevičius, J., Kapelenska-Pregowska, J., Kováč, P., et al. (2018) · Journal of Community Genetics · doi:10.1007/s12687-017-0344-2 · Cited by 93
Metadata
- Authors
- Vayena, E.
- Affiliations
- University of Zurich (CH)
- Corresponding author
- Vayena, Effy
- ORCID
- Vayena, Effy
- Venue
- Journal of Medical Ethics
- Publisher
- BMJ
- Published
- 2014-05-05
- Volume
- 41
- Issue
- 4
- Pages
- 310-314
- ISSN
- 0306-6800 (ISSN-L)
- 1473-4257
- PMC
- PMC4392219
- OpenAlex
- W2102719677
- Cited by
- 62
- References
- 44
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 7 · 2018: 8 · 2017: 7 · 2016: 10 · 2015: 4 · 2014: 5
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Journal of Medical Ethics (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics and bioethics in healthcare
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Social Sciences › Law › Medical and Health Sciences Research
- Keywords
- direct-to-consumer genetic testing, individual autonomy, Joseph Raz, manipulation, consumer autonomy, 23andMe, genetic privacy, regulatory policy
- MeSH terms
- Commerce, Community Participation, Genetic Counseling, Genetic Testing, Humans, Public Policy, United States, United States Food and Drug Administration, Genomics, Personal Autonomy, Marketing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.